Skip to content
Certified ManufacturersFor manufacturers

Bactolac Pharmaceutical, Inc.

Hauppauge, NY, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Bactolac Pharmaceutical, Inc. is a dietary supplement manufacturer in Hauppauge, NY, United States, certified to NSF/ANSI 455-2 GMP, with 3 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. It is also a USDA Organic certified operation. Listed dosage forms: capsules, powders, softgels and tablets.

Facilities listed
3
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Products on its USDA Organic certificate

Product types among the organic items that Bactolac Pharmaceutical, Inc.’s certified operation lists in the USDA Organic Integrity Database.

  • Collagen5 items
    • Collagen & Liver Caps
    • Collagen & Strawberry Caps
    • Collagen Caps
    • Organic Collagen Peptides
    • Collagen & Spirulina Caps

    As written in the USDA Organic Integrity Database.

    Collagen manufacturers →
  • Herbal & botanical2 items
    • Ashwagandha Capsules
    • Organic Peruvian Maca Caps

    As written in the USDA Organic Integrity Database.

    Herbal supplement manufacturers →
  • Protein8 items
    • Grass-Fed Whey Unflavored
    • Grass-Fed Whey Vanilla Bean
    • Bone Broth Protein - Vanilla (Powder)
    • Berry Green Protein Powder Strawberry Vanilla
    • Bone Broth Protein - Chocolate (Powder)
    • Bone Broth Protein - Unflavored
    • Protein Powder – Chocolate
    • Grass-Fed Whey Cacao Bean

    As written in the USDA Organic Integrity Database.

    Protein powder manufacturers →
  • Vitamins & minerals1 item
    • Vitamin D2 2000 IU

    As written in the USDA Organic Integrity Database.

    Vitamin manufacturers →
  • Mushrooms7 items
    • Chaga Mushroom Caps
    • Lion's Mane Mushroom Caps
    • Healthy Mushroom Capsules
    • Maitake Mushroom Caps
    • Multi Mushroom Caps
    • Cordyceps Mushroom Caps
    • Shiitake Mushroom Caps

    As written in the USDA Organic Integrity Database.

    Mushroom supplement manufacturers →

USDA Organic Integrity Database, operation 5520031255, checked .

These are organic items only: the certificate says nothing about the company’s non-organic products. A listed item is the certifier’s record of what the operation is certified to handle organically, not a test of the product. About USDA Organic item lists

Certified facilities

Manufacturing (3)

  • 7 Oser Avenue, Hauppauge, NY 11788, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Tablet Compression
    • Warehousing
  • 85 Davids Drive, Hauppauge, NY 11788, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 620 Old Willets Path, Hauppauge, NY 11788, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Tablet Compression
    • Warehousing

How Bactolac Pharmaceutical, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Bactolac Pharmaceutical, Inc. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 12 food or dietary supplement inspections at facilities matching Bactolac Pharmaceutical, Inc., from 2009 to 2025, as of . 5 found no objectionable conditions, 5 found conditions the firm was left to correct, and 2 led FDA to recommend official action.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    5 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))
    See all 5 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for purity and limits on contamination.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))

      You did not provide adequate documentation of your basis for determining that compliance with the specification(s) you selected for identity, purity, strength, composition, and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement will ensure that the finished batch of dietary supplement meets the specification(s).

    • Written procedures - follow; laboratory (21 CFR 111.303)

      You did not follow written procedures for laboratory operations.

    FEI 3000207006

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    5 citations posted:

    • Pest control measures (21 CFR 111.15(d)(2))
    • Specifications - components (21 CFR 111.70(b))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))
    See all 5 citations
    • Pest control measures (21 CFR 111.15(d)(2))

      You did not take effective measures to exclude pests from the physical plant and to protect against contamination of components, dietary supplements, and contact surfaces on the premises by pests.

    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish limits on contamination to ensure the quality of the dietary supplement.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))

      You did not provide adequate documentation of your basis for determining that compliance with the specification(s) you selected for identity, purity, strength, composition, and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement will ensure that the finished batch of dietary supplement meets the specification(s).

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held dietary supplements under conditions that lead to mix-up, contamination, or deterioration.

    FEI 3000207006

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    4 citations posted:

    • Specifications - contamination limits (21 CFR 111.70(e))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Specifications not met - reject, quality control (21 CFR 111.77(a))
    • Criteria for establishing specifications (21 CFR 111.315(a))
    Full citation text
    • Specifications - contamination limits (21 CFR 111.70(e))

      You did not establish product specifications for limits on contamination that may adulterate, or that may lead to adulteration of, the finished dietary supplement.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.

    • Specifications not met - reject, quality control (21 CFR 111.77(a))

      Your quality control personnel did not reject a component for which a specification was not met.

    • Criteria for establishing specifications (21 CFR 111.315(a))

      You did not establish laboratory control processes for use of criteria for establishing appropriate specifications.

    FEI 3000207006

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 3000207006

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 3000207006

Show all 12 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    5 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))
    See all 5 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for purity and limits on contamination.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))

      You did not provide adequate documentation of your basis for determining that compliance with the specification(s) you selected for identity, purity, strength, composition, and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement will ensure that the finished batch of dietary supplement meets the specification(s).

    • Written procedures - follow; laboratory (21 CFR 111.303)

      You did not follow written procedures for laboratory operations.

    FEI 3000207006

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    5 citations posted:

    • Pest control measures (21 CFR 111.15(d)(2))
    • Specifications - components (21 CFR 111.70(b))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))
    See all 5 citations
    • Pest control measures (21 CFR 111.15(d)(2))

      You did not take effective measures to exclude pests from the physical plant and to protect against contamination of components, dietary supplements, and contact surfaces on the premises by pests.

    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish limits on contamination to ensure the quality of the dietary supplement.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Specifications met identity, purity, strength, comp,; basis (21 CFR 111.75(c)(3))

      You did not provide adequate documentation of your basis for determining that compliance with the specification(s) you selected for identity, purity, strength, composition, and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement will ensure that the finished batch of dietary supplement meets the specification(s).

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held dietary supplements under conditions that lead to mix-up, contamination, or deterioration.

    FEI 3000207006

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    4 citations posted:

    • Specifications - contamination limits (21 CFR 111.70(e))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Specifications not met - reject, quality control (21 CFR 111.77(a))
    • Criteria for establishing specifications (21 CFR 111.315(a))
    Full citation text
    • Specifications - contamination limits (21 CFR 111.70(e))

      You did not establish product specifications for limits on contamination that may adulterate, or that may lead to adulteration of, the finished dietary supplement.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.

    • Specifications not met - reject, quality control (21 CFR 111.77(a))

      Your quality control personnel did not reject a component for which a specification was not met.

    • Criteria for establishing specifications (21 CFR 111.315(a))

      You did not establish laboratory control processes for use of criteria for establishing appropriate specifications.

    FEI 3000207006

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 3000207006

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 3000207006

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    2 citations posted:

    • Standard reference materials; criteria for selecting, QC (21 CFR 111.315(d))
    • Written procedures - product complaint (21 CFR 111.553)
    Full citation text
    • Standard reference materials; criteria for selecting, QC (21 CFR 111.315(d))

      Your laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations were not reviewed and approved by quality control personnel.

    • Written procedures - product complaint (21 CFR 111.553)

      You did not follow written procedures for the requirements to review and investigate a product complaint.

    FEI 3000207006

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Hauppauge, New York

    4 citations posted:

    • Physical plant - repair (21 CFR 111.15(b)(2))
    • Quality control - packaged, labeled (21 CFR 111.65)
    • Batch record - quality control review; monitoring (21 CFR 111.260(l)(1)(i))
    • Written procedures - holding (21 CFR 111.453)
    Full citation text
    • Physical plant - repair (21 CFR 111.15(b)(2))

      You did not maintain your physical plant in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

    • Quality control - packaged, labeled (21 CFR 111.65)

      You did not implement quality control operations to ensure that the dietary supplement is labeled as specified in the master manufacturing record.

    • Batch record - quality control review; monitoring (21 CFR 111.260(l)(1)(i))

      Your batch production records did not include documentation that quality control personnel reviewed required monitoring operations.

    • Written procedures - holding (21 CFR 111.453)

      You did not follow written procedures for holding and distributing operations.

    FEI 3000207006

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 3000207006

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Hauppauge, New York

    FEI 3000207006

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Hauppauge, New York

    FEI 3000207006

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 3000207006

  • No action indicated · No objectionable conditions found

    Inspected

    Hauppauge, New York

    FEI 3000207006

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What Bactolac Pharmaceutical, Inc. says it offers

From Bactolac Pharmaceutical, Inc.’s own website, checked . Not verified by us.

Products

  • Herbal & botanicalShow quote“Bactolac Pharmaceutical, Inc. is your trusted partner when it comes to private label herbal supplement manufacturing.”
    “Bactolac Pharmaceutical, Inc. is your trusted partner when it comes to private label herbal supplement manufacturing.”

    Source page · seen on

  • Pre-workoutShow quote“When it comes to formulating pre-workout supplements that deliver results, Bactolac is your go-to partner for success.”
    “When it comes to formulating pre-workout supplements that deliver results, Bactolac is your go-to partner for success.”

    Source page · seen on

  • Pet supplementsShow quote“As a producer of organic pet supplements for private label customers, we make sure to create a safe, natural and healthy product suited to your cat or dog’s needs.”
    “As a producer of organic pet supplements for private label customers, we make sure to create a safe, natural and healthy product suited to your cat or dog’s needs.”

    Source page · seen on

Services

  • Private labelShow quote“Fortunately, our abilities make us more than capable of serving as your custom contract manufacturer or providing private label services.”
    “Fortunately, our abilities make us more than capable of serving as your custom contract manufacturer or providing private label services.”

    Source page · seen on

  • Contract manufacturingShow quote“Bactolac Pharmaceutical is a leader in the nutraceutical industry, specializing in full turn-key nutritional supplement & vitamin contract manufacturing.”
    “Bactolac Pharmaceutical is a leader in the nutraceutical industry, specializing in full turn-key nutritional supplement & vitamin contract manufacturing.”

    Source page · seen on

  • TurnkeyShow quote“Bactolac offers more than just supplement contract manufacturing. We are a product development company that offers full turn-key solutions.”
    “Bactolac offers more than just supplement contract manufacturing. We are a product development company that offers full turn-key solutions.”

    Source page · seen on

  • Small batchesShow quote“Whether you require small-batch runs or large-scale manufacturing, our streamlined processes ensure efficient production without compromising on quality or precision.”
    “Whether you require small-batch runs or large-scale manufacturing, our streamlined processes ensure efficient production without compromising on quality or precision.”

    Source page · seen on

  • Packaging & bottlingShow quote“Whether you need bottles, blister packs, gusset bags, or wide-mouth jars, we offer customizable options including color, size, and closure types.”
    “Whether you need bottles, blister packs, gusset bags, or wide-mouth jars, we offer customizable options including color, size, and closure types.”

    Source page · seen on

  • Stick packs & sachetsShow quote“Our facilities are equipped with advanced, high-speed stick pack machinery designed for consistent and accurate filling of powders, granules, and even some viscous liquids.”
    “Our facilities are equipped with advanced, high-speed stick pack machinery designed for consistent and accurate filling of powders, granules, and even some viscous liquids.”

    Source page · seen on

Product certifications it claims

  • KosherShow quote“We’re also capable of producing Kosher and Halal supplements on request.”
    “We’re also capable of producing Kosher and Halal supplements on request.”

    Source page · seen on

  • HalalShow quote“We’re also capable of producing Kosher and Halal supplements on request.”
    “We’re also capable of producing Kosher and Halal supplements on request.”

    Source page · seen on

  • Organic productsShow quote“As a producer of organic pet supplements for private label customers, we make sure to create a safe, natural and healthy product suited to your cat or dog’s needs.”
    “As a producer of organic pet supplements for private label customers, we make sure to create a safe, natural and healthy product suited to your cat or dog’s needs.”

    Source page · seen on

We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims

What we checked, and what we didn’t

Confirmed from public registry listings

Last checked

  • NSF/ANSI 455-2 GMP certification
  • USDA Organic certified operation
  • 3 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility
  • Product types on its USDA Organic certificate (organic items only)

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.
  • What the company’s own website says it makes and offers, shown above with quotes

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026